BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 30, 1999
View Archived Issues
Genzyme General: Q1 1999 highlights
Read More
Novel pressure-mediated drug delivery technology available for licensing from NIH
Read More
Copernicus obtains broad patent protection for nucleic acid delivery technology
Read More
Spotlight on treatment of attention deficit hyperactivity disorder
Read More
Celebrex launched in Canada for arthritis
Read More
Vitravene recommended for European approval as CMV retinitis therapy
Read More
Schering-Plough: Annual Report 1998
Read More
Ethyol granted E.U. approval for use in radiation therapy
Read More
Amylin's pramlintide given trademark
Read More
Mallinckrodt takes over Optison manufacturing
Read More
DuPont presents new series of HIV reverse transcriptase inhibitors
Read More
Protease inhibitors in development at SmithKline Beecham
Read More
Urea-based compounds from AHP increase HDL cholesterol levels
Read More
Inhibitors of 5alpha-reductase claimed by L'Oreal for androgen-dependent skin disorders
Read More
New oxazolidinones claimed by Zeneca (AstraZeneca)
Read More
Merck researchers prepare potential antipsychotic compounds with reduced side effects
Read More
NG-061: a novel fungal metabolite with neurotrophic effects in PC12 cells
Read More
Potent and selective small-molecule thrombin inhibitor developed at DuPont
Read More
PDL issued U.S. patent covering its SMART anti-CD3 antibody
Read More
Patent provides Cortex exclusive use of AMPA receptor modulators for improving memory, cognition
Read More
GeneSwitch technology patent coverage expanded
Read More
Mammastatin cleared for clinical trials in late-stage breast cancer
Read More
Iomai demonstrates feasibility and safety of transcutaneous immunization
Read More
NDA filed for first oral neuraminidase inhibitor for the flu
Read More
Company Profile: Vaxis Therapeutics
Read More
SK-951 identified as a potent 5-HT4 agonist/5-HT3 antagonist
Read More
Phase I pharmacokinetic, safety and efficacy results reported for KNI-272
Read More
Company Profile: Genetix
Read More